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Neurosurgical Forum

LETTERS TO THE EDITOR

Long-term efficacy of ETV and
shunt surgery for management of
hydrocephalus
TO THE EDITOR: We read with interest the article
by Beuriat et al.1 regarding management of hydrocephalus
and its long-term outcome (Beuriat PA, Puget S, Cinalli
G, et al: Hydrocephalus treatment in children: long-term
outcome in 975 consecutive patients. J Neurosurg Pediatr
20:10–18, July 2017).
We commend the authors for undertaking this study,
with one of the longest follow-up periods in a pediatric
population with hydrocephalus. The etiologies of hydrocephalus that may impact the long-term efficacy of the
treatment and complications of shunt placement have been
systematically classified and recorded. However, we would
like to bring forth a few issues concerning the article that
need further consideration. We observe that this study
was undertaken with the aim to understand the preferable
treatment modality for hydrocephalus. The two primary
modalities studied here were endoscopic third ventriculostomy (ETV) and shunt surgery. In both these treatment
groups, the authors noted that there is significant contribution of the etiology of hydrocephalus to determining the
long-term efficacy of surgical treatment. We observed in
the article’s survival curves that different etiologies responded better to the two treatments. Thus, it would be
clinically relevant to know which treatment works better
for a particular etiology. And consequently, the comparison of the two treatment modalities for each of the common etiologies must have been done to contribute to the
clinical decision making. We also note that the ETV and
shunt groups differ systematically in terms of the etiology
of hydrocephalus. Thus, for an overall comparison of ETV
and shunt surgery, a multivariate analysis must have been
performed, eliminating the impact of etiology difference.
The classification of etiologies is an elaborate and comprehensive task. However, we find that there are some instances that might be clinically erroneous in spite of being
pathologically correct. As an example, cases of postinfectious and posttraumatic hydrocephalus have been clubbed
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together in the inflammatory group, although the two
groups may have a systematic difference in the long-term
outcomes in lieu of the etiology. Thus, we suggest that they
should have been grouped and analyzed separately and
compared with each other. Also, the tumoral group has
not been further classified into posterior fossa and supratentorial tumors, and all patients who underwent ETV had
posterior fossa tumors, which might also have an impact
on efficacy. These errors in classification have resulted in
missing out on a few clinically important findings that this
study would have contributed.
It is also notable that in the Orbis Sigma Valve (OSV)
shunt group the best outcome occurred in those belonging
to the “others” group of etiology. It would have been very
informative if the authors had mentioned the specific etiologies comprising this group.
The authors have taken note of the fact that there was
a systematic difference with regard to the surgeons performing OSV and differential-pressure valve shunt surgeries and also the small number of patients belonging
to the differential-pressure valve group, which might be
contributing to the differences observed in the long-term
outcomes between the two shunts.
In their review of the literature the authors noted a
much lower success rate for shunt surgery in other studies
compared to their study.2,3 However there was no attempt
by the authors to explain the probable reasons for these
observed differences in the outcome measures.
One of the merits of this study is that it had one of the
longest follow-up durations. This merit has not been used
to the full extent. The authors noted that several patients
required repeat procedures after failure of the first surgery. In understanding the long-term outcomes of the patients with hydrocephalus, it is important to understand
not only the rate of failure and need for second surgery
but also the outcome of the second surgery. And thus we
believe that it would have been beneficial if an analysis of
the outcomes of redo ETVs and secondary shunt surgeries
after initial ETV or shunt surgery had also been reported.
Additionally, comparison between the efficacy of primary and secondary surgery and comparison between
ETV and shunt surgery when performed as the secondary
surgery should have been done.

J Neurosurg Pediatr Volume 21 • January 2018
Unauthenticated | Downloaded 07/04/22 03:45 PM UTC

Neurosurgical forum

In conclusion, we would like to say that although this
study has undoubtedly highlighted many clinically important findings, it fails to shed light on several important
aspects of the topic.
Ravi Sharma, MBBS
Manoj Phalak, MCh
Vivek Tandon, MCh
Ashok K. Mahapatra, MCh

All India Institute of Medical Sciences, New Delhi, India
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Biomechanical vulnerability with
second concussion
TO THE EDITOR: I read with interest the article by
Post et al.1 demonstrating no increase in biomechanical vulnerability among patients who have experienced
a repeat concussion compared to those with their first
concussion (Post A, Hoshizaki TB, Gilchrist MD, et al:
A comparison in a youth population between those with
and without a history of concussion using biomechanical
reconstruction. J Neurosurg Pediatr 19:502–510, April
2017). They do not give any data on the time between the
first and second concussions among the study patients. An
article published by my group demonstrated that the time
between concussions could be critical.2 We found that
patients who had a second concussion within 1 year recovered more quickly than patients with a first concussion
or those who had a second concussion more than 1 year
after their first. We hypothesized that patients who experience head trauma within 1 year of a concussion did have
increased vulnerability to a second concussion. Furthermore, patients concussed with less biomechanical force
recovered more quickly.
Post et al. could examine the validity of our hypothesis

by comparing 3 groups within those patients with repeat
concussions: those occurring within 6 months, 6 months to
1 year, and more than a year. I urge them to do so. If on further analysis of their data, they find that patients who suffer
a concussion are more vulnerable to a second one within the
1st year, it would be an important factor in deciding when to
allow patients to return to contact sports or other activities
in which there is an increased risk of head trauma.
One caveat to consider is that all the patients in their
study were recruited from emergency visits. None of our
patients with a recurrent concussion within a year presented to an emergency department (ED). They were first seen
in our primary care pediatric office. In many of these patients, the chief complaint, unlike most concussed patients,
was not head trauma but headache or dizziness. Therefore,
if our hypothesis is validated, the physician caring for a
patient who has had a concussive episode within a year
will need to look for evidence of head trauma and a second
concussion even if the chief complaint is not head trauma.
Bruce Taubman, MD

Advocare Cherry Hill Pediatric Group, Cherry Hill, NJ
Perelman School of Medicine at the University of Pennsylvania,
Philadelphia, PA
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We thank Dr. Taubman for his interest in this research
paper. We read with interest the paper that his group published examining the recovery time for patients with a history, or no history, of concussion. The differences in the
results between the Dr. Taubman’s paper and this work
may be reflected in differences in methods, specifically
the subject sample and the dependent variables. The data
set from our paper included a pediatric cohort that presented to tertiary pediatric EDs, whereas in the article
by Taubman et al.,5 the study included participants who
presented to primary care clinics. This difference in the
populations might affect a comparison of results given
the possibility that the ED population may have presented
with greater initial symptom burden or more severe mechanism of injury. Additionally, Taubman et al.5 focused on
the recovery of the patients, using neurocognitive testing,
and how previous concussions can affect this outcome. In
our study we focused on dependent variables that were entirely biomechanical in nature, with no quantification of
recovery time based on previous head injury history. We
concur that it would be valuable in the future to examine
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the relationship between the biomechanics of impact and
the association with neurocognitive outcomes and recovery times in pediatric concussion.
We also wanted to address the comment regarding the
timing between the first and second concussions. Since
many participants included in our analysis had more than
2 concussions, we defined the historical group as 1 or more
concussions. Given that the objective of our study was to
ascertain if the vulnerability of brain tissues would be evident using biomechanical reconstruction analysis, the anatomical and tissue research would support Dr. Taubman’s
hypothesis that there would be a vulnerability within a given time frame following a concussion and also that lower
biomechanical forces might affect recovery time.1–4 As a
result, windows of vulnerability related to tissue responses
can be measured post-impact. Unfortunately, in reconstruction work, the magnitude of impact that created the concussion was not controlled. As a result it may be that the youth
impacted in this study would have received a concussion
regardless of the tissue’s vulnerability, since the event was
of such severity that a brain injury would have occurred regardless. This may have increased the likelihood that there
would be no observed difference between the history and
no-history groups as described in the paper.
Andrew Post, PhD1,2
T. Blaine Hoshizaki, PhD2
Michael D. Gilchrist, PhD3
David Koncan, MSc2
Lauren Dawson, MSc2
Wesley Chen, BSc2
Andrée-Anne Ledoux, PhD1
Roger Zemek, MD1
Pediatric Emergency Research Canada (PERC)
5P Concussion Team
Children’s Hospital of Eastern Ontario Research Institute,
Ottawa, ON, Canada
2
Human Kinetics, University of Ottawa, Ottawa, ON, Canada
3
School of Mechanical & Materials Engineering, University College,
Dublin, Ireland
1
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Hoshizaki, PhD; Peter Anderson, PhD; Brian L. Brooks, PhD;
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Keightley, PhD; Lawrence Richer, MD; and Carol DeMatteo, MSc.
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Posterior fossa tumor resection
and the failure of endoscopic
third ventriculostomy and
ventriculoperitoneal shunts
TO THE EDITOR: I read with interest the recent article by Dewan et al.3 (Dewan MC, Lim J, Shannon CN, et
al: The durability of endoscopic third ventriculostomy and
ventriculoperitoneal shunts in children with hydrocephalus following posterior fossa tumor resection: a systematic
review and time-to-failure analysis. J Neurosurg Pediatr
19:578–584, May 2017). I wish to commend the authors for
this work involving both a systematic selection and review
of 12 publications indexed in PubMed and a retrospective
review of their own series of posterior fossa brain tumor
(PFBT) patients requiring CSF diversion. They report that
endoscopic third ventriculostomy (ETV) failure occurred
sooner than ventriculoperitoneal shunt (VPS) failure, that
long-term treatment durability was found to be higher for
ETV, and that complications occurred more frequently
with VPS than with ETV. Although they mention that
postoperatively about 30% of patients will have persistent
hydrocephalus requiring permanent CSF diversion, the authors do not clearly state whether all 12 studies included
in the analysis strictly examined only postoperative cases
of hydrocephalus occurring after excision of PFBT, or
whether some of the studies also included patients treated
for hydrocephalus prior to PFBT excision or persisting after surgery. Instead, they simply mention that the analysis
between ETV and VPS involved patients treated for hydrocephalus related to PFBT, both for the studies from the
systematic review and for their own retrospective series.3
There are a few logical reasons to support recommending ETV for patients with hydrocephalus arising from lowgrade lesions, who have a probability of longer survival,
and VPS for hydrocephalus occurring as a result of the
more aggressive PFBT, with limited survival.3 Endoscopic
third ventriculostomy has been suggested as the procedure
of choice following postoperative cases of hydrocephalus
over VPS, though there is still insufficient information
from the literature to support this.2,4,6,7 Some studies have
confirmed the high success rate and low complication
rate of ETV.5 One series reported that ETV successfully
controlled all 8 cases of post–PFBT excision hydrocepha-
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lus, even when there was already subarachnoid seeding at
the time of ETV.7 Progressive hydrocephalus as a result
of subsequent shunt failure in 3 patients in another series
was successfully managed with ETV.2 Furthermore, when
done prior to PFBT resection, ETV has been shown to
significantly reduce the risk of postoperative hydrocephalus.1,7 These benefits are important for patients with PFBT
in whom longer survival is anticipated.
On the other hand, the risk, commonly associated with
VPS, of peritoneal seeding via the CSF may not really be
a significant problem as a possible complication of CSF
diversion for hydrocephalus following resection of more
aggressive lesions because of the shorter life expectancy
often associated with such lesions. Moreover, even though
VPS has a greater tendency for complications than ETV,
as clearly demonstrated, the shorter life expectancy characteristic of the recurrence of more aggressive lesions is
often not likely to provide sufficient time for any of the
common VPS complications to occur before the death of
the patient from tumor progression. However, as the authors rightly mention, issues like these remain quite uncertain and definitely require multi-institutional collaboration
and thoughtful study design to be objectively confirmed.
Chiazor U. Onyia, MBBS

Obafemi Awolowo University Teaching Hospitals Complex, Ile-Ife, Nigeria
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We appreciate the thoughtful response offered by Dr.
Onyia. This is an important topic, and fruitful discourse
is needed if we are to move closer to definitive answers.
Regarding the query posed in the letter, our systematic
review did not stipulate a specific timing of CSF diversion relative to PFBT resection. As mentioned among our
study’s limitations, many source articles did not specify
relative timing for individuals. Particularly in mixedcohort studies (those describing both pre- and postresection ETV), survival data often could not be disaggregated.
Thus, in an effort to maximize ETV patients and strengthen the comparison, preresection ETV was not an exclusion
criterion. Is it then possible that some patients in the metaregressed ETV cohort underwent CSF diversion unnecessarily, as they would not have been destined to persistent
hydrocephalus? This is indeed possible. It is why we were
careful to remind the reader that our results should be interpreted as a summary of published data, rather than as
definitive evidence to pursue one treatment modality over
the other. Bias and dissimilar comparator groups are just
two reasons why practice standards are best not built on
retrospective uncontrolled analyses.
It is relevant to note that at our institution, preresection
ETV is never performed, as we believe that doing so would
unnecessarily expose the majority of patients who do not
develop persistent hydrocephalus to the risks of an invasive procedure. This is all despite the low risk profile of
ETV, which is illustrated in our systematic review.
Dr. Onyia has echoed several of the most important
concepts underlying the decision to treat PFBT-related
hydrocephalus with ETV or VPS. Among them he refers
to the differential survival duration based on tumor grade,
the risk of subarachnoid and peritoneal seeding, and, of
course, the success rates reported by other surgeons. So
while there are many factors available to guide today’s
neurosurgeon in this treatment decision, one of the most
important is absent: high-quality evidence. Fortunately,
unlike many clinical variables that are not modifiable, as a
community of neurosurgeons we have the ability to change
this. Our study suggests that equipoise exists, and a randomized clinical trial comparing ETV and VPS in these
patients seems not only sensible, but necessary.
Michael C. Dewan, MD, MSCI
John C. Wellons III, MD, MSPH

Vanderbilt University Medical School, Nashville, TN
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